News Home

Should You Hold Corbus Pharmaceuticals Holdings Inc (CRBP) in Biotechnology Industry?

Thursday, January 20, 2022 02:37 PM | InvestorsObserver Analysts
Should You Hold Corbus Pharmaceuticals Holdings Inc (CRBP) in Biotechnology Industry?

A rating of 84 puts Corbus Pharmaceuticals Holdings Inc (CRBP) near the top of the Biotechnology industry according to InvestorsObserver. Corbus Pharmaceuticals Holdings Inc's score of 84 means it scores higher than 84% of stocks in the industry. Corbus Pharmaceuticals Holdings Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 110 out of the 148 industries.

Overall Score - 51
CRBP has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on CRBP!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 51 would rank higher than 51 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes


’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Corbus Pharmaceuticals Holdings Inc Stock Today?

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is trading at $0.53 as of 2:33 PM on Thursday, Jan 20, an increase of $0.02, or 4.78% from the previous closing price of $0.51. The stock has traded between $0.52 and $0.55 so far today. Volume today is low. So far 428,883 shares have traded compared to average volume of 994,641 shares. Click Here to get the full Stock Report for Corbus Pharmaceuticals Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App